Home › Neurologic Diseases › Washington
Neurologic Diseases clinical trials in Washington
6 studies for Neurologic Diseases are looking for participants at sites in Washington.
Cities in Washington
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Bellevue
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Product Surveillance Registry
- Bremerton
- Seattle
- Spokane
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615The "What Is Important to Us" Communication Intervention Pilot Clinical Trial
- Seattle Children's Hospital, Seattle
RecruitingPhase 2
6 Months · All sexes · Updated Feb 18, 2026 · NCT06208332Transcutaneous Stimulation for Neurological Populations
- University of Washington, Seattle
Recruiting
Ages 4 to 70 · All sexes · Updated Sep 19, 2024 · NCT04467437From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.